Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial

BACKGROUND: EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation evaluated use of nonvitamin K antagonist oral anticoagulant edoxaban vs enoxaparin‐warfarin in patients with nonvalvular atrial fibrillation undergoing electrical cardioversion. HYPOTHESIS: To assess cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lip, Gregory Y. H., Merino, Jose L., Banach, Maciej, Al‐Saady, Naab, Jin, James, Melino, Michael, Winters, Shannon M., Kozieł, Monika, Goette, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279960/
https://www.ncbi.nlm.nih.gov/pubmed/32528568
http://dx.doi.org/10.1002/joa3.12341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279960/
https://www.ncbi.nlm.nih.gov/pubmed/32528568
http://dx.doi.org/10.1002/joa3.12341

Ejemplares similares